A citation-based method for searching scientific literature


List of co-cited articles
475 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Antiviral drug resistance of human cytomegalovirus.
Nell S Lurain, Sunwen Chou. Clin Microbiol Rev 2010
346
22

Human cytomegalovirus resistance to antiviral drugs.
C Gilbert, G Boivin. Antimicrob Agents Chemother 2005
149
14

Antiviral drugs for cytomegalovirus diseases.
Karen K Biron. Antiviral Res 2006
291
14

Oral activity of a methylenecyclopropane analog, cyclopropavir, in animal models for cytomegalovirus infections.
Earl R Kern, Deborah J Bidanset, Caroll B Hartline, Zhaohua Yan, Jiri Zemlicka, Debra C Quenelle. Antimicrob Agents Chemother 2004
57
14

In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replication.
Earl R Kern, Nicole L Kushner, Caroll B Hartline, Stephanie L Williams-Aziz, Emma A Harden, Shaoman Zhou, Jiri Zemlicka, Mark N Prichard. Antimicrob Agents Chemother 2005
68
12


Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial.
David W Kimberlin, Chin-Yu Lin, Pablo J S├ínchez, Gail J Demmler, Wayne Dankner, Mark Shelton, Richard F Jacobs, Wendy Vaudry, Robert F Pass, Jan M Kiell,[...]. J Pediatr 2003
525
11

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation.
Camille N Kotton, Deepali Kumar, Angela M Caliendo, Anders Asberg, Sunwen Chou, David R Snydman, Upton Allen, Atul Humar. Transplantation 2010
405
11

Human cytomegalovirus UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma protein and inhibits the formation of nuclear aggresomes.
Mark N Prichard, Elizabeth Sztul, Shannon L Daily, Amie L Perry, Samuel L Frederick, Rachel B Gill, Caroll B Hartline, Daniel N Streblow, Susan M Varnum, Richard D Smith,[...]. J Virol 2008
84
11

In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246.
Peter Lischka, Guy Hewlett, Tobias Wunberg, Judith Baumeister, Daniela Paulsen, Thomas Goldner, Helga Ruebsamen-Schaeff, Holger Zimmermann. Antimicrob Agents Chemother 2010
162
11

Drug targets in cytomegalovirus infection.
Graciella Andrei, Erik De Clercq, Robert Snoeck. Infect Disord Drug Targets 2009
59
11

Seroprevalence of cytomegalovirus infection in the United States, 1988-1994.
Stephanie A S Staras, Sheila C Dollard, Kay W Radford, W Dana Flanders, Robert F Pass, Michael J Cannon. Clin Infect Dis 2006
585
9

Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients.
Andre C Kalil, Josh Levitsky, Elizabeth Lyden, Julie Stoner, Alison G Freifeld. Ann Intern Med 2005
265
9

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients.
Carlos Paya, Atul Humar, Ed Dominguez, Kenneth Washburn, Emily Blumberg, Barbara Alexander, Richard Freeman, Nigel Heaton, Mark D Pescovitz. Am J Transplant 2004
596
9

High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy.
Ajit P Limaye, Ganesh Raghu, David M Koelle, James Ferrenberg, Meei-Li Huang, Michael Boeckh. J Infect Dis 2002
167
9





A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency.
M N Prichard, N Gao, S Jairath, G Mulamba, P Krosky, D M Coen, B O Parker, G S Pari. J Virol 1999
153
9

Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action.
Karen K Biron, Robert J Harvey, Stanley C Chamberlain, Steven S Good, Albert A Smith, Michelle G Davis, Christine L Talarico, Wayne H Miller, Robert Ferris, Ronna E Dornsife,[...]. Antimicrob Agents Chemother 2002
244
9


Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir.
Sunwen Chou, Rachel H Waldemer, Anne E Senters, Kevin S Michels, George W Kemble, Richard C Miner, W Lawrence Drew. J Infect Dis 2002
135
9

Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro.
Stephanie L Williams-Aziz, Caroll B Hartline, Emma A Harden, Shannon L Daily, Mark N Prichard, Nicole L Kushner, James R Beadle, W Brad Wan, Karl Y Hostetler, Earl R Kern. Antimicrob Agents Chemother 2005
91
9

Cytomegalovirus in transplantation - challenging the status quo.
Jay A Fishman, Vincent Emery, Richard Freeman, Manuel Pascual, Lionel Rostaing, Hans J Schlitt, Dino Sgarabotto, Julian Torre-Cisneros, Marc E Uknis. Clin Transplant 2007
198
8

Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains.
T A Cha, E Tom, G W Kemble, G M Duke, E S Mocarski, R R Spaete. J Virol 1996
510
8

Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms.
Christian Gilbert, Julie Bestman-Smith, Guy Boivin. Drug Resist Updat 2002
210
8

Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action.
J Reefschlaeger, W Bender, S Hallenberger, O Weber, P Eckenberg, S Goldmann, M Haerter, I Buerger, J Trappe, J A Herrington,[...]. J Antimicrob Chemother 2001
74
8

Phenotyping of cytomegalovirus drug resistance mutations by using recombinant viruses incorporating a reporter gene.
Sunwen Chou, Laura C Van Wechel, Heather M Lichy, Gail I Marousek. Antimicrob Agents Chemother 2005
92
8



In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses.
Stephanie L Williams, Caroll B Hartline, Nicole L Kushner, Emma A Harden, Deborah J Bidanset, John C Drach, Leroy B Townsend, Mark R Underwood, Karen K Biron, Earl R Kern. Antimicrob Agents Chemother 2003
98
8

Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.
Guy Boivin, Nathalie Goyette, Halvor Rollag, Alan G Jardine, Mark D Pescovitz, Anders Asberg, Jane Ives, Anders Hartmann, Atul Humar. Antivir Ther 2009
69
8

Clinical impact of ganciclovir-resistant cytomegalovirus infections in solid organ transplant patients.
G Boivin, N Goyette, C Gilbert, A Humar, E Covington. Transpl Infect Dis 2005
67
8

Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56.
P M Krosky, M R Underwood, S R Turk, K W Feng, R K Jain, R G Ptak, A C Westerman, K K Biron, L B Townsend, J C Drach. J Virol 1998
141
8

Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies.
Lauren Nassetta, David Kimberlin, Richard Whitley. J Antimicrob Chemother 2009
80
8

Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus.
Sunwen Chou, Nell S Lurain, Kenneth D Thompson, Richard C Miner, W Lawrence Drew. J Infect Dis 2003
134
8

Oral activity of ether lipid ester prodrugs of cidofovir against experimental human cytomegalovirus infection.
Deborah J Bidanset, James R Beadle, W Brad Wan, Karl Y Hostetler, Earl R Kern. J Infect Dis 2004
58
8

Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney.
Stephanie L Ciesla, Julissa Trahan, W Brad Wan, James R Beadle, Kathy A Aldern, George R Painter, Karl Y Hostetler. Antiviral Res 2003
131
8

Stereoselective phosphorylation of cyclopropavir by pUL97 and competitive inhibition by maribavir.
Brian G Gentry, Jeremy P Kamil, Donald M Coen, Jiri Zemlicka, John C Drach. Antimicrob Agents Chemother 2010
36
13

Definitions of cytomegalovirus infection and disease in transplant recipients.
Per Ljungman, Paul Griffiths, Carlos Paya. Clin Infect Dis 2002
920
8


Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies.
Michael Boeckh, W Garrett Nichols, Genovefa Papanicolaou, Robert Rubin, John R Wingard, John Zaia. Biol Blood Marrow Transplant 2003
302
8

Passive immunization during pregnancy for congenital cytomegalovirus infection.
Giovanni Nigro, Stuart P Adler, Renato La Torre, Al M Best. N Engl J Med 2005
480
6

Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity.
Michael Boeckh, Wendy Leisenring, Stanley R Riddell, Raleigh A Bowden, Meei-Li Huang, David Myerson, Terry Stevens-Ayers, Mary E D Flowers, Terri Cunningham, Lawrence Corey. Blood 2003
421
6

A trial of valganciclovir prophylaxis for cytomegalovirus prevention in lung transplant recipients.
Atul Humar, Deepali Kumar, Jutta Preiksaitis, Guy Boivin, Deborah Siegal, Jayne Fenton, Kathy Jackson, Sarah Nia, Dale Lien. Am J Transplant 2005
67
6


Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients.
Nell S Lurain, Sangeeta M Bhorade, Kenneth J Pursell, Robin K Avery, Vijay V Yeldandi, Carlos M Isada, Emmanuel S Robert, Debra J Kohn, Max Q Arens, Edward R Garrity,[...]. J Infect Dis 2002
83
6

High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes.
I L Smith, J M Cherrington, R E Jiles, M D Fuller, W R Freeman, S A Spector. J Infect Dis 1997
195
6



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.